Upper Norwood Medical Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 7433236

Upper Norwood Medical Limited

Filleted Unaudited Financial Statements

31 December 2024

Upper Norwood Medical Limited

Statement of Financial Position

31 December 2024

	2024		2023
Note	£	£	£

Current assets

Debtors	5	206,116	213,378
Cash at bank and in hand		183,041	155,569
		---------	---------
		389,157	368,947

Creditors: amounts falling due within one year	6	7,897		2,508
		---------		---------
Net current assets			381,260	366,439
			---------	---------
Total assets less current liabilities			381,260	366,439
			---------	---------
Net assets			381,260	366,439
			---------	---------

Capital and reserves

Called up share capital	200	200
Profit and loss account	381,060	366,239
	---------	---------
Shareholders funds	381,260	366,439
	---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Upper Norwood Medical Limited

Statement of Financial Position (continued)

31 December 2024

These financial statements were approved by the board of directors and authorised for issue on 21 August 2025 , and are signed on behalf of the board by:

Dr S Sivathasan	Dr D Virdi
Director	Director

Dr Y Patel	Dr R Selvanathan
Director	Director

Company registration number: 7433236

Upper Norwood Medical Limited

Notes to the Financial Statements

Year ended 31 December 2024

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 130 Church Road, Upper Norwood, London, SE19 2NT.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 4 (2023: 4 ).

5. Debtors

	2024	2023
	£	£
Trade debtors	–	7,262
Other debtors	206,116	206,116
	---------	---------
	206,116	213,378
	---------	---------

6. Creditors: amounts falling due within one year

	2024	2023
	£	£
Corporation tax	5,329	–
Other creditors	2,568	2,508
	-------	-------
	7,897	2,508
	-------	-------

7. Related party transactions

There were no transactions that need to be disclosed under Financial Reporting Standard For Smaller Entities.